Prof. Dr. TANER DAMCI

Yayın Ağı

Makaleler 12

1. The Role of Obesity in Predicting the Clinical Outcomes of COVID-19

ŞAHİN S., Sezer H., ÇİÇEK E., Yagiz Ozogul Y., YILDIRIM M., Icli T. B., et al.

OBESITY FACTS , cilt.14, sa.5, ss.481-489, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

2. Serum Level of Cytokeratin-18/M30 Antigen is Increased in the Cases with Impaired Glucose Tolerance

Himmetoğlu Ş., Yüksel S., DAMCI T., İLKOVA H. M., DİNCER Y.

Int Arch Endocrinol Clin Res , cilt.3, sa.1, ss.1-5, 2017 (Hakemli Dergi)

3. Exploring the characteristics of suboptimally controlled patients after 24 weeks of basal insulin treatment: An individualized approach to intensification

Khunti K., Damci T., Husemoen L. L., Babu V., Liebl A.

DIABETES RESEARCH AND CLINICAL PRACTICE , cilt.123, ss.209-217, 2017 (SCI-Expanded, Scopus)

4. The International Diabetes Management Practices Study (IDMPS) - Turkey's 5(th) Wave Results

Ilkova H., Damci T., Karsidag K., ÇÖMLEKÇİ A., Ayvaz G.

TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM , cilt.20, sa.3, ss.88-96, 2016 (ESCI, Scopus, TRDizin)

5. Lower risk of hypoglycaemia and greater odds for weight loss with initiation of insulin detemir compared with insulin glargine in Turkish patients with type 2 diabetes mellitus: local results of a multinational observational study

Damci T., Emral R., Svendsen A. L., Balkir T., Vora J.

BMC ENDOCRINE DISORDERS , cilt.14, 2014 (SCI-Expanded, Scopus)

6. Initiation of once daily insulin detemir is not associated with weight gain in patients with type 2 diabetes mellitus: results from an observational study

Yale J., Damci T., Kaiser M., Karnieli E., Khunti K., Liebl A., et al.

DIABETOLOGY & METABOLIC SYNDROME , cilt.5, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

7. Comparison of a soluble co-formulation of insulin degludec/insulin aspart vs biphasic insulin aspart 30 in type 2 diabetes: a randomised trial

Niskanen L., Leiter L. A., Franek E., Weng J., Damci T., Munoz-Torres M., et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY , cilt.167, sa.2, ss.287-294, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

8. Glucose intolerance, insulin resistance, and C peptide levels in patients with spinal cord injury

Oekul I., Uenalan H., Erhan B., Damci T., Uludag M.

NEUROSURGERY QUARTERLY , cilt.17, sa.3, ss.170-174, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

9. Celiac disease in an adult Turkish population with type 1 diabetes mellitus

AYGUN C., URAZ S., DAMCI T., OSAR Z., Yumuk V. D., AKDENIZLI E., et al.

DIGESTIVE DISEASES AND SCIENCES , cilt.50, sa.8, ss.1462-1466, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

10. Orlistat augments postprandial increases in glucagon-like peptide-1 in obese type 2 diabetic patients - Response to Horowitz et al.

Damci T., YALIN S., Balci H., Osar Z., KORUGAN Ü., ÖZYAZAR M., et al.

DIABETES CARE , cilt.27, sa.11, ss.2771, 2004 (SCI-Expanded, Scopus)

11. Orlistat augments postprandial increases in glucagon-like peptide 1 in obese type 2 diabetic patients

Damci T., YALIN S., Balci H., Osar Z., KORUGAN Ü., ÖZYAZAR M., et al.

DIABETES CARE , cilt.27, sa.5, ss.1077-1080, 2004 (SCI-Expanded, Scopus)

12. Diabetik hastada gelişen nonklostridial anaerobik selülit

Ersanlı Z., DAMCI T., Karayiğit T., Çerçel A., ÖZTÜRK R., MERT A., et al.

Cerrahpaşa Tıp Fak Derg , cilt.27, ss.216-220, 1996 (Hakemli Dergi) Sürdürülebilir Kalkınma

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

168

H-İndeks (WoS)

Atıf (Scopus)

193

H-İndeks (Scopus)

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler